Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

35.86 -0.33 (-0.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,426,517
Open 36.20
Bid (Size) 35.83 (5)
Ask (Size) 35.84 (5)
Prev. Close 36.19
Today's Range 35.80 - 36.53
52wk Range 24.05 - 38.00
Shares Outstanding 388,132,400
Dividend Yield 2.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Here's How Much $1000 Invested In Royalty Pharma 15 Years Ago Would Be Worth Today
 
Via Benzinga
RPRX Q2 Deep Dive: Margins Compress Despite Solid Royalty Growth and Strategic Investments
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 7.7% year on year to $578.7 million. Its non-GAAP profit of $1.14... 
Via StockStory

Performance

YTD
+39.0%
+39.0%
1 Month
-1.0%
-1.0%
3 Month
+7.5%
+7.5%
6 Month
+13.1%
+13.1%
1 Year
+35.6%
+35.6%

More News

Read More
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Royalty Pharma (NASDAQ:RPRX)
Via StockStory
Topics Artificial Intelligence Intellectual Property
Royalty Pharma (RPRX) Q2 Receipts Up 20%
Via The Motley Fool
Earnings Scheduled For August 6, 2025
Via Benzinga
A Look Into Royalty Pharma Inc's Price Over Earnings
Via Benzinga
How Is The Market Feeling About Royalty Pharma?
Via Benzinga
Royalty Pharma PLC (NASDAQ:RPRX) Exceeds Q2 2025 Earnings Estimates and Raises Full-Year Guidance
Via Chartmill
Royalty Pharma (NASDAQ:RPRX) Misses Q2 Revenue Estimates
Via StockStory
Royalty Pharma Reports Second Quarter 2025 Results
From Royalty Pharma plc
Via GlobeNewswire
Earnings To Watch: Royalty Pharma (RPRX) Reports Q2 Results Tomorrow
Via StockStory
Topics Government World Trade
2 Reasons to Watch RPRX and 1 to Stay Cautious
Via StockStory
Topics Stocks
3 Profitable Stocks to Research Further
Via StockStory
Topics Supply Chain
Royalty Pharma Declares Third Quarter 2025 Dividend
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
From Royalty Pharma plc
Via GlobeNewswire
Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
From Royalty Pharma plc
Via GlobeNewswire
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Via Benzinga
2 Surging Stocks to Research Further and 1 to Be Wary Of
Via StockStory
Revolution Medicines To Advance Lead Cancer Drug With $2 Billion In Funds
Via Benzinga
Revolution Medicines To Get Up To $2B For Development Of Cancer Drug From Royalty Pharma
Via Stocktwits
Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
From Royalty Pharma plc
Via GlobeNewswire
Q1 Rundown: Royalty Pharma (NASDAQ:RPRX) Vs Other Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
RPRX Q1 Earnings Call: Flat Revenue, Portfolio Expansion, and Capital Return Initiatives
Via StockStory
2 Value Stocks to Target This Week and 1 to Turn Down
Via StockStory
Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
From Royalty Pharma plc
Via GlobeNewswire

Frequently Asked Questions

Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 35.86
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 08/12/25 04:00 PM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 13.92B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.